Ann: OncoSil receives Swiss regulatory approval, page-9

First 9 Last

Share
Profile

Follow
JohnTCH

456 Posts.

116

06/11/20

13:42

Post #: 48689504
Share

Originally posted by vrs37: ↑

possibly. You’d think they surely get one sale from somewhere in Europe by year end. But...
•••..look at the numbers..company communication to market says 40,000 locally adv pancreatic cancer cases per year in Europe plus UK. (4,500 in UK.)
••That means by end of year there will have been 30,000 new lapc cases in Europe since award of CE mark. Over 3000 in Uk alone.
•• so as far as we know as of today there not one sale from 30,000 cases. Not one sale in uk from potential market 3,000. Not even from doctors and hospitals in London already set up to use device from their experience on Plancko trial?
so interesting question is what’s the real extent of demand for the device? Do u think one sale by year end in Uk really would cut it for major re-rate?

Expand

omg u r still holding this stock?
u should liquidate and already made some decent coins?

hello..!!! covid happened? on boarding was delayed. the sales team in europe has just been appointment not long ago?

Jeeze. the rain stopped but the worms still wriggle out to put their 2 negative bobs worth in.

repeat on loop... lol

you asked about the panco trial with passion on the charts thread and that was recently addressed in an ann. and now u sing a different tune?

go away and relax.

GLTAH and all imo and DYOR

OSL Price at posting: 16.5¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

LTR

Liontown locks in $266M placement to help cashflow, Kathleen Valley ramp-up

Oz will likely unveil commodity price supports, but don't expect Trumpian flare

Thursday's HotCopper trends: $266M LTR placement, Trigg expansion | Aug 7

MQR

'We're extremely encouraged': Marquee expands footprint at Mt Clement

ASX Market Close: Health Care stocks lead index lower | August 7, 2025

First 9 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.11		Change 0.025(2.30%)		Mkt cap ! $20.89M

Open	High	Low	Value	Volume
$1.09	$1.11	$1.09	$26.73K	24.35K

Buyers (Bids)

No.	Vol.	Price($)
1	6807	$1.11

Sellers (Offers)

Price($)	Vol.	No.
$1.12	6617	1

View Market Depth

No.	Vol.	Price($)
1	6807	1.110
1	4500	1.100
2	10900	1.080
2	4000	1.070
1	77	1.065

Price($)	Vol.	No.
1.120	6617	1
1.140	5000	1
1.145	5000	1
1.150	6938	1
1.180	5000	1

Last trade - 16.10pm 07/08/2025 (20 minute delay)

OSL (ASX) Chart

Ann: OncoSil receives Swiss regulatory approval, page-9

Liontown locks in $266M placement to help cashflow, Kathleen Valley ramp-up

Oz will likely unveil commodity price supports, but don't expect Trumpian flare

Thursday's HotCopper trends: $266M LTR placement, Trigg expansion | Aug 7

'We're extremely encouraged': Marquee expands footprint at Mt Clement

ASX Market Close: Health Care stocks lead index lower | August 7, 2025

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: OncoSil receives Swiss regulatory approval, page-9

Top Stories

Liontown locks in $266M placement to help cashflow, Kathleen Valley ramp-up

Oz will likely unveil commodity price supports, but don't expect Trumpian flare

Thursday's HotCopper trends: $266M LTR placement, Trigg expansion | Aug 7

'We're extremely encouraged': Marquee expands footprint at Mt Clement

ASX Market Close: Health Care stocks lead index lower | August 7, 2025

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News